Apple now makes one in four iPhones in India: report

Apple now manufactures 25% of iPhones in India (about 55 million of ~220–230 million global units last year), reflecting a material shift in production away from China. India shipped 14 million iPhones last year (+9% YoY) and surpassed $9 billion in iPhone sales, while Apple began building the entire iPhone 17 lineup in India and says most U.S. demand is now filled by India-made units. The move accelerated in 2025 amid U.S. tariff uncertainty and drew direct political attention (Trump warned CEO Tim Cook), and Apple is expanding retail/fintech presence there (6th store opened; Apple Pay talks).

Analysis

Apple’s ongoing production diversification is a classic example of real option hedging: near-term unit economics take a hit as Apple seeds capacity outside the highly integrated Chinese ecosystem, but the option value is reduced exposure to abrupt tariff or regulatory shocks. I estimate an initial margin headwind in the low-to-mid single digits as suppliers and logistics rewire, with the potential for breakeven on a unit basis inside 18–36 months if component localization accelerates and unit volumes scale.

Second-order winners are not consumer-facing brands but EMS and component suppliers that can replicate China’s dense ecosystem in India — firms that control capital expenditure, land acquisition, and supplier management will capture outsized returns as customers consolidate upstream spend. Conversely, smaller China-only tier-2/3 suppliers and regional logistics hubs in Southeast Asia face structural volume loss unless they pivot or establish India footprints; this creates a multi-year reallocation of capex and M&A opportunities in the supplier base.

Key catalysts and risks are lumpy and political: expect headline-driven volatility over days/weeks tied to tariff statements or summit-level interventions, while technical yield, quality, and supply-chain completeness will determine the 6–24 month fundamental path. A rapid rollback of U.S. tariff pressure or a Chinese policy response (subsidies, faster supplier consolidation) could reverse capital flows quickly; operational risks in India (labor actions, land permitting, currency moves) are non-linear and would delay margin recovery.

The market’s implicit consensus treats diversification as binary risk mitigation; that underweights the transitory margin squeeze and overweights speed of supplier localization. Real alpha is in firms that bridge component complexity to India — not in headline winners — so focus on execution-enabled suppliers and hedge political/timing risk on the core equity exposure.

Key Decisions for Investors

• Directional AAPL (12–24 months): Buy long-dated call spreads (LEAPS) to capture upside from services monetization and improved geopolitical optionality; fund with short-dated calls to reduce premium. Target 30–40% upside; max loss = premium paid. Monitor quarterly supply-chain commentary as roll/trim signals.
• Supply-chain pair (6–18 months): Long Hon Hai / Short China-centric EMS (e.g., Luxshare) to express benefit to firms that already operate India capacity. Size modest (3–6% portfolio), target 2:1 reward/risk given materially higher probability of incremental India revenues for Hon Hai; cut if Indian capex guidance misses by >20% y/y.
• Insurance trade (0–12 months): Buy 6–9 month AAPL downside puts ~5–10% OTM or buy a collar around a core long to protect vs abrupt tariff/political headlines. Cost is insurance against a >10% drawdown from policy shock; unwind once political noise subsides or delivery metrics stabilize.
• Event/opportunistic (3–12 months): Monitor Indian payments/retail infrastructure names for a tactical long if Apple Pay launch triggers faster monetization — enter on consolidation after launch-confirmation, size small and pair with a short regional incumbent if regulatory tail risks materialize.